Archive for November 2017

The primary endpoint of brain atrophy as defined by PBVC from baseline to week 48, was not met after daily oral doses with 0.6 mg laquinimod. Source: BioSpace

Speculation has increased that Amazon might enter the pharmacy market after it conducted high-level talks with generic drug companies Mylan and Sandoz, a division of Novartis. Source: BioSpace

These great biotech stocks to buy for the holidays come in all sizes — small-cap, mid-cap, and large-cap. Source: BioSpace

An IDMC told Bayer that it should unblind its Phase III clinical trial in prostate cancer in order to further analyze an increased number of fractures and deaths. Source: BioSpace

The spike began after the six-person company announced it had entered into a multi-year services agreement with Merck KGaA. Source: BioSpace

Foundation Medicine’s sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday. Source: BioSpace

HeartFlow makes software that builds a 3D model of your heart’s arteries, based on CT scans. Source: BioSpace

There are some changes taking place in the C-suites at Shire. Source: BioSpace

Astellas is pulling the trigger on an acquisition option from a partnership deal the two companies formed in 2013. Source: BioSpace

In an analysis of BMS’ recent clinical history, Industry analysts at Trefis noted that two oncology drugs will be key revenue drivers for the company. Source: BioSpace